Disclosures for "Advanced Targeting Techniques in MRgFUS Thalamotomy for Tremor: A Systematic Review "
-
Mr. Melott has nothing to disclose.
-
Kate Gelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Neuroscience. Kate Gelman has stock in Neuralink Corp.
-
Mr. Mendelson has nothing to disclose.
-
Dr. Khan has nothing to disclose.
-
Peter Konrad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic.
-
The institution of Dr. Memon has received research support from NIH/NINDS.